TRDA EBITDA Margin

Entrada Therapeutics Inc · EBITDA Margin

TRDA logo

TRDA EBITDA Margin

Latest reported-3518.31%
TRDA TTM EBITDA Margin (-293.04% → -3518.31%)
High-resolution chart · PNG

TRDA ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Entrada Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-3,518.3099%
-2,873.3357%
-560.1707%
-163.0218%
-91.8466%
16.0225%
33.3321%
37.1404%
62.0668%
48.2192%
38.5178%
17.9613%
-144.2735%
-293.0443%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.